Cel-Sci Receives $2.1 Million From Warrant Exercises

Vienna, VA, June 27, 2018 -- CEL-SCI Corporation (NYSE American: CVM), in response to shareholder questions, updates its shareholders on the amount of money received from warrant exercises since April 1, 2018. Since that time CEL-SCI has received $2,133,677 through the exercise of warrants by investors to purchase the Company's common stock. The...

 

Vienna, VA, June 27, 2018 -- CEL-SCI Corporation (NYSE American: CVM), in response to shareholder questions, updates its shareholders on the amount of money received from warrant exercises since April 1, 2018. Since that time CEL-SCI has received $2,133,677 through the exercise of warrants by investors to purchase the Company's common stock. The number of shares outstanding is 19,518,106.

About CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.

 

 

Source: www.cel-sci.com